DALL'OLIO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 3.025
EU - Europa 1.803
AS - Asia 1.316
AF - Africa 94
SA - Sud America 14
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.256
Nazione #
US - Stati Uniti d'America 3.014
SG - Singapore 573
GB - Regno Unito 488
CN - Cina 432
IT - Italia 331
DE - Germania 250
SE - Svezia 151
IN - India 106
IE - Irlanda 100
VN - Vietnam 100
UA - Ucraina 99
CH - Svizzera 76
FR - Francia 75
RU - Federazione Russa 74
BG - Bulgaria 53
ZA - Sudafrica 42
TG - Togo 40
EE - Estonia 38
JO - Giordania 26
HK - Hong Kong 16
ID - Indonesia 16
BE - Belgio 12
AT - Austria 11
ES - Italia 11
JP - Giappone 11
CA - Canada 9
NL - Olanda 9
CL - Cile 8
FI - Finlandia 8
IR - Iran 8
SC - Seychelles 8
KR - Corea 7
BR - Brasile 6
GR - Grecia 6
LB - Libano 5
TR - Turchia 4
TW - Taiwan 4
AU - Australia 3
CI - Costa d'Avorio 3
HR - Croazia 3
RO - Romania 3
CZ - Repubblica Ceca 2
MX - Messico 2
PH - Filippine 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
CD - Congo 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
MY - Malesia 1
PL - Polonia 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 6.256
Città #
Singapore 519
Southend 432
Fairfield 341
Ashburn 242
Woodbridge 190
Santa Clara 170
Houston 167
Wilmington 166
Chandler 155
Cambridge 150
Seattle 133
Ann Arbor 125
Princeton 121
Boardman 112
Dublin 100
Bologna 93
Bern 72
Jacksonville 64
Sofia 53
Nanjing 49
Westminster 49
Dong Ket 45
Lomé 40
Padova 40
Berlin 38
Shenyang 29
Jinan 27
Amman 26
Beijing 25
Falls Church 24
San Diego 24
Shanghai 24
Milan 23
Redmond 22
Saint Petersburg 22
Hebei 19
Nanchang 18
Norwalk 17
Jakarta 16
Hanover 15
Medford 15
Changsha 14
Redwood City 14
Rome 14
Fuzhou 13
Guangzhou 13
Mülheim 13
Brussels 12
Hong Kong 12
Zhengzhou 12
Des Moines 11
Olalla 11
Salsomaggiore Terme 10
Vienna 9
Jiaxing 8
Los Angeles 8
Mahé 8
Hangzhou 7
Helsinki 7
San Francisco 7
Taizhou 7
Tianjin 7
Tokyo 7
Toronto 7
Barcelona 6
Haikou 6
Ningbo 6
Wuhan 6
Xi'an 6
Boretto 5
Boston 5
Chengdu 5
Dearborn 5
Frankfurt am Main 5
London 5
Modena 5
Rimini 5
Seongnam 5
Shijiazhuang 5
Taiyuan 5
Boydton 4
Cento 4
Chicago 4
Civitanova Marche 4
Lille 4
Phoenix 4
Portici 4
Springfield 4
Abidjan 3
Andover 3
Benevento 3
Bremen 3
Bühl 3
Forlì 3
Frankfurt Am Main 3
Istanbul 3
Lanzhou 3
Linyi 3
Moscow 3
Mountain View 3
Totale 4.396
Nome #
Identification of novel plasma glycosylation-associated markers of aging 160
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon 150
The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach 134
B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract 134
Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression. 131
High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid 125
Increased brain-predicted aging in treated HIV disease 125
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling 124
Apoptotic cells selectively uptake minor glycoforms of vitronectin from serum 123
ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines 120
Biosynthesis of the Sda determinant by beta1,4 N-acetylgalactosaminyltransferase in normal and cancer colon: relationship with sialyl Lewis X expression 118
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types 118
Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer 117
The extended cytoplasmic tail of the human B4GALNT2 is critical for its Golgi targeting and post-Golgi sorting 115
Role of Bifidobacterium longum in the induction of apoptotic deletion in the human enterocyte-like Caco-2 cell line 114
Selectin ligands Sialyl-Lewis a and Sialyl-Lewis x in gastrointestinal cancers 110
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer 110
Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1 109
Bladder cancer–glycosylation insights 107
Expression of beta-galactoside alpha 2,6 sialyltransferase and of alpha 2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis 107
Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage 106
Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation 106
Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF mediated signal to its housekeeping promoter. 103
beta-galactoside alpha2,6-sialyltransferase and the sialyl alpha 2,6-galactosyl-linkage in tissues and cell lines 101
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation 100
Epigenetic Bases of Aberrant Glycosylation in Cancer 100
Mechanisms of cancer-associated glycosylation changes 99
Exposure of alpha2,6-sialylated lactosaminic chains marks apoptotic and necrotic death in different cell types 96
N-glycomic biomarkers of biological aging and longevity: A link with inflammaging 95
Control of Glycosylation-Related Genes by DNA Methylation: the Intriguing Case of the B3GALT5 Gene and Its Distinct Promoters. 95
Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements 94
Lectin from Elder (Sambucus nigra) as a marker of apoptotic and necrotic death 93
Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers. 93
Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. 92
Surface alpha2-3- and alpha2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis 90
The expanding roles of the Sda/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2 90
A novel non-sense and inactivating variant of ST3GAL3 in two infant siblings suffering severe epilepsy and expressing circulating CA19.9 90
Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy. 89
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition 88
DNA methylation and histone modifications modulate the beta1,3 galactosyltransferase beta3Gal-T5 native promoter in cancer cells 83
Glycobiology of the epithelial to mesenchymal transition 82
Increased substratum adhesion and beta1 integrin expression in human colon cancer cells transduced with alpha2,6 sialyltransferase (ST6Gal.I) 81
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive Impairment 80
Glycobiology of Aging 78
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy 78
Glycosylation in cancer 75
Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948. 73
L1cam as an e-selectin ligand in colon cancer 71
Control of sialyl Lewis X antigen expression in the colon by fucosyltransferase VI and beta4 GalNAcT-II 70
Glycosyltransferase b4galnt2 as a predictor of good prognosis in colon cancer: Lessons from databases 70
The expression of Sda beta1,4 N-acetylgalactosaminyltransferase inhibits sialyl Lewis X expression in colon cancer cells 67
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models 67
Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours 66
In vivo growth advantage of colon cancer cell lines expressing beta-galactoside alpha 2,6 sialyltransferase (ST6Gal.I) 66
Molecular bases of sialyl Lewis x overexpression in colon cancer 57
The cancer-associated antigens sialyl lewisa/x and sda: Two opposite faces of terminal glycosylation 55
Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions 49
Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry 46
N-Glycan on the Non-Consensus N-X-C Glycosylation Site Impacts Activity, Stability, and Localization of the Sda Synthase B4GALNT2 37
The story of the Sda antigen and of its cognate enzyme B4GALNT2: What is new? 33
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions 31
Expression of UDP-GalNAc:NeuAc alpha 2,3Gal beta-R beta 1,4(GalNAc to Gal) N-acetylgalactosaminyltransferase involved in the synthesis of Sda antigen in human large intestine and colorectal carcinomas 30
Enhanced CMP‐NeuAc:Galβ1, 4GlcNAc‐R α2, 6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft‐derived cell lines 29
Comparative study on O-linked oligosaccharides of glycoprotein D of herpes simplex virus types 1 and 2 28
Differentiation-dependent expression of human beta-galactoside alpha2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells 28
Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues 27
Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus 26
Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter 25
A tetraantennary glycopeptide from human Tamm-Horsfall glycoprotein inhibits agglutination of desialylated erythrocytes induced by leucoagglutinin 25
Expression of β-galactoside α2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis 24
β-Galactoside α2,6 sialyltransferase in human colon cancer: Contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin 24
Characterization and partial purification of β-N-acetylgalactosaminyltransferase from urine of Sd(a+) individuals 23
Effect of Acute and Chronic Ethanol Administration on Rat Liver α 2,6‐Sialyltransferase Activity Responsible for Sialylation of Serum Transferrin 23
N-acetylgalactosaminyltransferase activity involved in O-glycosylation of herpes simplex virus type 1 glycoproteins 22
Characterization of N-acetyl-beta-d-galactosaminyl-transferase from guinea-pig kidney involved in the biosynthesis of Sda antigen associated with Tamm-Horsfall glycoprotein 22
Immunosuppressive activity of tamm-horsfall glycoprotein oligosaccharides: Effect of removal of outer sugars and conjugation with a protein carrier 21
Cell surface N-acetylneuraminic acid α2,3-galactoside-dependent intercellular adhesion of human colon cancer cells 20
Effect of Ethanol on Human Colon Carcinoma CaCo‐2 and HT‐29 Cell Lines during the Maturation Process 20
Differential expression of the hepatic transcript of β-galactoside α2,6-sialyltransferase in human colon cancer cell lines 19
Sialyltransferases in cancer 18
The expression of soluble and cell-bound α2,6 sialyltransferase in human colonic carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation 18
Postnatal development of rat colon epithelial cells is associated with changes in the expression of the beta 1,4-N-acetylgalactosaminyltransferase involved in the synthesis of Sda antigen of alpha 2,6-sialyltransferase activity towards N-acetyl-lactosamine 17
Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form 17
Oligosaccharide chains of herpes simplex virus type 2 glycoprotein gG.2 17
Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA 16
Temporal aspects of O-glycosylation of glycoprotein C from herpes simplex virus type-1 16
Sialylated oligosaccharides O-glycosidically linked to glycoprotein C from herpes simplex virus type 1 15
Identification and characterization of the Sda beta1,4,N-acetylgalactosaminyltransferase from pig large intestine 14
Guinea pig kidney β-N-acetylgalactosaminyltransferase towards Tamm-Horsfall glycoprotein. Requirement of sialic acid in the acceptor for transferase activity 14
Tissue distribution and age-dependent expression of β-4-N-acetylgalactosaminyltransferase in guinea-pig 14
UDP-Ga1NAc:NeuAcα2,3Galβ-R (GaINAc to Gal) β1,4-N-acetyl-galactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line 14
Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine 14
N-and O-glycosylation of glycoprotein C synthesized by Herpes simplex virus type 1-infected ricin resistant cells 14
Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC 12
High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein 12
Processing of herpes simplex virus-1 glycans in cells defective in glycosyl transferases of the golgi system: Relationship to cell fusion and virion egress 12
Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation 11
The sialyl-α2,6-lactosaminyl-structure: Biosynthesis and functional role 11
Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I 11
Resistance to methotrexate is associated with selective changes of α2,6- and α2,3-sialyltransferase activities toward N-acetyllactosaminic sequences in human colon cancer cell line HT-29 11
Totale 6.420
Categoria #
all - tutte 20.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020836 0 0 0 0 0 0 184 177 193 108 68 106
2020/2021757 148 53 12 55 28 51 18 43 75 68 39 167
2021/20221.040 55 52 67 35 101 70 46 73 44 26 293 178
2022/20231.157 121 119 71 100 118 72 38 53 202 37 60 166
2023/2024363 17 87 30 29 36 44 40 14 13 30 11 12
2024/20251.242 198 301 141 239 293 69 1 0 0 0 0 0
Totale 6.442